Genotype–phenotype correlation in partial combined 17α-hydroxylase/17,20-lyase deficiency: functional characterization of CYP17A1 variants in ten 46,XY patients

Clicks: 22
ID: 332337
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #124 of 448 articles by views in the journal of clinical endocrinology & metabolism

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 448 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Partial combined 17α-hydroxylase/17,20-lyase deficiency (PC-17OHD) is a rare 17OHD subtype with residual 17α-hydroxylase and 17,20-lyase activities. In 46,XY individuals, genital virilization is highly variable, and genotype–phenotype correlations remain poorly defined. Objective To characterize the clinical and endocrine spectrum of 46,XY PC-17OHD, functionally validate uncharacterized CYP17A1 variants, and establish genotype–phenotype correlations. Methods We enrolled ten 46,XY PC-17OHD patients from 9 families. Clinical phenotypes were characterized, and long-read CYP17A1 sequencing was performed. Splicing effects and enzyme activities were evaluated by minigene assays and HEK293T functional studies, respectively. Variants were classified according to ACMG guidelines. Results All patients presented with the triad of elevated mineralocorticoid precursors, generalized androgen suppression, and preserved cortisol levels. Median age at diagnosis was 17.5 years, with hypertension in 30% (3/10) and hypokalemia in 20% (2/10). Ten distinct variants were identified, including 2 novel splice-site variants (c.666+2T>C, c.1243+2T>G). Haplotype analysis revealed a shared identical haplotype among 5 patients carrying the c.1263G>A allele, indicating a Chinese founder effect. Four uncharacterized variants showed residual 17α-hydroxylase/17,20-lyase activities: p.Trp499Ter (11%/6.3%), p.Ala448Val (22.5%/14.2%), p.Leu433Ser (25.9%/21.7%), and c.666+2T>C (28.9%/22.6%). Notably, 2 patients with identical genotypes (c.985_987delinsAA/c.1263G>A) exhibited drastically divergent phenotypes—hypospadias (raised male) vs complete female external genitalia (raised female)—indicating that genotype alone cannot accurately predict clinical phenotypes in PC-17OHD. Conclusions Residual CYP17A1 activity largely determines genital masculinization, while marked phenotypic heterogeneity among patients with identical genotypes indicates that genotype alone cannot fully predict clinical manifestations. These findings improve molecular diagnosis and individualized care for this disorder.
Reference Key
openalex_W7221769350 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Yaqing Cao, Lin Lü, Ming Li, Anli Tong, Shi Chen, Wei Zhang, Chenjie Guo, Chuang Wang, Xi Wang, Jiangfeng Mao, Xueyan Wu, Min Nie
Are you one of these authors? Claim your profile
Journal the journal of clinical endocrinology & metabolism
Year 2026
DOI
10.1210/clinem/dgag363
URL
https://doi.org/10.1210/clinem/dgag363
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.